Therapeutic Hypothermia for Severe Traumatic Brain Injury in Japan

NCT ID: NCT00134472

Last Updated: 2012-05-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2002-12-31

Study Completion Date

2008-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this trial is to determine if mild hypothermia therapy, for severe head trauma patients, improves neurological outcome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Mild hypothermia therapy shows protective effects for damaged brains of animals and post cardiac arrest patients. However, Clifton et al. reported that mild hypothermia has no protective effect for severe head trauma but has a risk of complications. In this study, all the participants must be treated with continuous monitoring of cardiac output and jugular venous oxygen saturation to get optimal physiological conditions. Adequate anesthesia such as neuroleptanesthesia is essential to maintain organ function and tissue microcirculation. Participants are randomly assigned to two groups of mild hypothermia (32.0 - 34.0 degree Celsius) and anti-hyperthermia (35.5 - 37.0 C). The body temperature must be kept for at least 72 hours. Hypothermia must be induced within 6 hours after traumatic brain injury. Glasgow outcome score at 6 months after injury and the total medical expenses of the two groups will be evaluated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Brain Injuries, Traumatic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Therapeutic mild hypothermia

Keeping 32 - 34 degree celsius of core temperature at least for 72 hours.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Traumatic brain injury; Glasgow coma score 4-8 (motor 1-5).
* Hypothermia or anti-hyperthermia must be induced within 6 hours after injury.

Exclusion Criteria

* Systolic blood pressure \< 90mmHg (after resuscitation)
* Thrombocytopenia (platelets \[Plt\] \< 50,000/mm3)
* Pregnancy
* Preexisting medical conditions of severe hepatic dysfunction, heart failure or any other severe organ failure
* Deep drunkenness
Minimum Eligible Age

15 Years

Maximum Eligible Age

69 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Medical Information Network

OTHER

Sponsor Role collaborator

Japan Clinical Research Support Unit(J-CRSU)

UNKNOWN

Sponsor Role collaborator

Yamaguchi University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tsuyoshi Maekawa

Honorary Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tsuyoshi Maekawa, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Yamaguchi University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Hospital Organization Nagoya Medical Center

Nagoya, Aichi-ken, Japan

Site Status

Nagoya University Hospital

Nagoya, Aichi-ken, Japan

Site Status

Fujita Health University Hospital

Toyoake, Aichi-ken, Japan

Site Status

Chiba University Hospital

Chiba, Chiba, Japan

Site Status

Chiba Emergency Medical Center

Chiba, Chiba, Japan

Site Status

Ehime University Hospital

Tōon, Ehime, Japan

Site Status

Ohta Nishinouchi Hospital

kooriyama, Fukushima, Japan

Site Status

Gifu University Hospital

Gifu, Gifu, Japan

Site Status

Sapporo Medical University

Sapporo, Hokkaido, Japan

Site Status

The Hospital of Hyogo College of Medicine

Nishinomiya, Hyōgo, Japan

Site Status

Kanazawa University

Kanazawa, Ishikawa-ken, Japan

Site Status

Iwate Medical University

Morioka, Iwate, Japan

Site Status

Kagawa University Hospital

Kida, Kagawa-ken, Japan

Site Status

St. Marianna University, School of Medicine

Kawasaki, Kanagawa, Japan

Site Status

Kitasato University

Sagamihara, Kanagawa, Japan

Site Status

Yokohama City Seibu Hospital

Yokohama, Kanagawa, Japan

Site Status

Aizawa Hospital

Matsumoto, Nagano, Japan

Site Status

Shinshu University Hospital

Matsumoto, Nagano, Japan

Site Status

Nara Medical University

Kashihara, Nara, Japan

Site Status

Oita University Faculty of Medicine

Ōita, Oita Prefecture, Japan

Site Status

Kawasaki Medical University

Kurashiki, Okayama-ken, Japan

Site Status

National Hospital Organization Osaka National Hospital

Cyuo, Osaka, Japan

Site Status

Kansai Medical University

Moriguchi, Osaka, Japan

Site Status

Osaka Mishima Emergency Medical Center

Takatsuki, Osaka, Japan

Site Status

Saga Prefectural Hospital Kouseikan

Saga, Saga-ken, Japan

Site Status

Saitama Medical Center

Kawagoe, Saitama, Japan

Site Status

Shiga University of Medical Science

Ōtsu, Shiga, Japan

Site Status

Saiseikai Utsunomiya Hospital

Utsunomiya, Tochigi, Japan

Site Status

Tokushima University Hospital

Kuramoto, Tokushima, Japan

Site Status

Nippon Medical School

Bunkyo, Tokyo, Japan

Site Status

The University of Tokyo Hospital

Bunkyo, Tokyo, Japan

Site Status

Tokyo Medical University Hachioji Medical Center

Hachiōji, Tokyo, Japan

Site Status

National Hospital Organization Tokyo Medical Center

Meguro City, Tokyo, Japan

Site Status

Kyorin University Hospital

Mitaka, Tokyo, Japan

Site Status

Musashino Red Cross Hospital

Musashino, Tokyo, Japan

Site Status

Toho University Omori Medical Center

Ōta-ku, Tokyo, Japan

Site Status

Showa University Hospital

Shinagawa, Tokyo, Japan

Site Status

Tokyo Medical University

Shinjuku, Tokyo, Japan

Site Status

Teikyo University Hospital

tabashi City, Tokyo, Japan

Site Status

Nihon University Itabashi Hospital

tabashi City, Tokyo, Japan

Site Status

Tama Nagayama Hospital, Nippon Medical School

Tama, Tokyo, Japan

Site Status

Yamagata University Hospital

Yamagata, Yamagata, Japan

Site Status

Advanced Medical Emergency and Critical Care Center, Yamaguchi University Hospital

Ube, Yamaguchi, Japan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Japan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H15-HEART-01

Identifier Type: -

Identifier Source: secondary_id

H16-HEART-01

Identifier Type: -

Identifier Source: secondary_id

H14-HEART-005

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

California Transport Cooling Trial
NCT01683383 COMPLETED NA
Weighted Blankets After Brain Injury
NCT04860973 TERMINATED NA